Tag: products

HOUSTON, July 01, 2025 (GLOBE NEWSWIRE) -- Occidental (NYSE: OXY) will announce its second quarter 2025 financial results after close of market on Wednesday, August 6, 2025, and will hold a conference call to discuss the results on Thursday, August 7, 2025, at 1 p.m. Eastern/12 p.m. Central.

In this 2025 public health alignment update, GlucoTru Pro emphasizes the growing consumer awareness of natural metabolic support strategies, including non-synthetic approaches to managing blood pressure, blood sugar, and overall wellness. This release provides new insights into public commentary themes, recent transparency in ingredient sourcing, and the alignment of the GlucoTru Pro formula with broader non-pharmaceutical health discussions.

HOUSTON, TX, July 01, 2025 (GLOBE NEWSWIRE) -- In a move to strengthen its leadership following a strategic share exchange with Abundia Global Impact Group (AGIG), Houston American Energy Corp. (NYSE American: HUSA) (“HUSA” or the “Company”) today announced the appointment of Matthew T. Henninger to its Board of Directors, effective immediately. Mr. Henninger will serve on the Audit Committee and Compensation Committees.

" Comprehensive Analysis of Market Dynamics, Emerging Technologies, and Clean-Label Trends Shaping the Future of the Global Carotenoids Industry"

HOUSTON, TX, July 01, 2025 (GLOBE NEWSWIRE) -- Houston American Energy Corp. (NYSE American: HUSA) (“HUSA” or the “Company”) has completed its acquisition of Abundia Global Impact Group, LLC (“AGIG”), creating a leading company focused on converting waste plastics into high-value, drop-in low-carbon fuels and chemical products.

ST. LOUIS, July 01, 2025 (GLOBE NEWSWIRE) --

Today’s pet parents want real, whole-food nutrition that they can recognize and trust. That’s exactly what NEW Instinct® FreshRaw™ Meals deliver. This first-of-its-kind offering combines real, fresh ingredients you can see with the superior nutrition of raw. 

Press release – Paris, July 1^st, 2025, at 7:00 P.M. CEST

WINSTON-SALEM, N.C., July 01, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced the completion of the domestication process to change the jurisdiction of incorporation of the Company from the Cayman Islands to Delaware. The domestication was approved by shareholders of the Company at its Annual General Meeting held on May 29, 2025. Effective as of July 1, 2025, each (i) Class A ordinary share automatically converted into one share of Class A common stock of ProKidney Corp., a Delaware corporation and (ii) each Class B ordinary share automatically converted into one share of Class B common stock of ProKidney. ProKidney common stock will begin trading on July 2, 2025, and the Company's trading symbol on the Nasdaq Stock Market will remain unchanged as "PROK." The Company’s CUSIP number relating to its Class A common stock changed to 74291D 104. The Company does not anticipate any impact to day-to-day business operations as a result of the domestication.